SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023190
Filing Date
2022-11-08
Accepted
2022-11-08 16:03:28
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctmx-20220930.htm   iXBRL 10-Q 3171703
2 EX-10.1 ctmx-ex10_1.htm EX-10.1 121091
3 EX-10.2 ctmx-ex10_2.htm EX-10.2 121020
4 EX-10.3 ctmx-ex10_3.htm EX-10.3 83302
5 EX-10.4 ctmx-ex10_4.htm EX-10.4 82583
6 EX-10.5 ctmx-ex10_5.htm EX-10.5 82925
7 EX-10.6 ctmx-ex10_6.htm EX-10.6 70924
8 EX-31.1 ctmx-ex31_1.htm EX-31.1 21797
9 EX-31.2 ctmx-ex31_2.htm EX-31.2 21847
10 EX-32.1 ctmx-ex32_1.htm EX-32.1 15225
11 EX-32.2 ctmx-ex32_2.htm EX-32.2 15274
  Complete submission text file 0000950170-22-023190.txt   9393008

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctmx-20220930_def.xml EX-101.DEF 193179
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctmx-20220930_lab.xml EX-101.LAB 337887
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctmx-20220930_pre.xml EX-101.PRE 298358
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctmx-20220930.xsd EX-101.SCH 43572
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctmx-20220930_cal.xml EX-101.CAL 34741
60 EXTRACTED XBRL INSTANCE DOCUMENT ctmx-20220930_htm.xml XML 1494434
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 221368795
SIC: 2834 Pharmaceutical Preparations